Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CRAWFORD & COMPANY

(CRD.B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Crawford mpany : Coronavirus (CONVID-19) impact on Mergers & Acquisitions

03/12/2020 | 11:24pm EDT

Crawford's Chief Strategy Officer, Greta Van takes a look at the global impact of CONVID-19 and how it could impact Mergers and Acquisitions.

The global impact of CONVID-19, or Coronavirus, is one that no business can ignore. Roughly 90,000 cases and 3,000 deaths have been reported to date, and those numbers are climbing. From business interruption to travel restrictions, the effects are complex and costly. For those in the insurance industry, there is increased pressure to answer inquiries about policies, potential risks to clients, and how to protect employees. The outbreak is a global issue and touches all aspects of the business, including mergers and acquisitions (M&A).

What was the state of M&A before CONVID-19?

Before the outbreak, the M&A world saw a wave of super-sized mergers in the U.S., each worth more than $10 billion, driving corporate deal-making to its fourth-strongest year on record. For the insurance industry, in particular, mergers increased in the third quarter by 51.2%, according to Property Casualty 360, and in the U.S. alone, there were 625 M&A transactions.

How will CONVID-19 affect the M&A sector?

The costs of keeping the virus in check are mounting and are liable to surpass all previous outbreaks. With entire cities under quarantine and companies scaling back operations or completely shutting down, M&A and Joint Venture (JV) transactions across the world are undoubtedly at risk as we navigate these uncertain times.

The coronavirus outbreak can be expected to slow M&A in the insurance industry as companies will weigh the benefits of moving forward until the contagion is under control. We should not, however, deter due diligence and strategic considerations when eyeing target companies. During a recent interview with CNBC, Warren Buffet noted that a very significant percentage of businesses were being impacted by the Coronavirus, adding, '…the real question is where those businesses are going to be in five to 10 years.'

What can we expect in the future?

Looking ahead, we may be dealing with the effects of the CONVID-19 for years to come. This pandemic has caused many companies to reevaluate their current M&A deals, and investors can expect uncertainty, particularly when dealing with global companies. Those currently involved in transactions could see the Coronavirus effects triggering a material adverse change (MAC) clause. The outbreak may also constitute a 'force majeure' with the event being beyond the control of both parties. There could be delays to closings, delays to due diligence, breach of warranties, or any number of termination events. We must consider timing carefully when moving forward with so many uncertainties at play, especially in an already unstable market. With no available vaccine on the market, investors should note that things may get much worse before they get better.

Disclaimer

Crawford & Company published this content on 13 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 March 2020 04:22:11 UTC


© Publicnow 2020
All news about CRAWFORD & COMPANY
06/14CRAWFORD MPANY  : Cyber Risk - To pay or not to pay, that is the question
PU
06/13REFILE-ANALYSIS-With Trump gone, NATO wages war on climate threat
RE
06/11Amazon Got Us Hooked on One-Day Delivery -- Now Small Businesses Are Paying f..
DJ
06/08INSULET  : Significant Insider Selling in Shares of Insulet (PODD) Continues
MT
06/07INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Insulet
MT
06/07CRAWFORD MPANY  : Giving back, one tree at a time
PU
06/03PRESS RELEASE : Novartis 177Lu-PSMA-617 -2-
DJ
06/01U.S. says ransomware attack on meatpacker JBS likely from Russia
RE
06/01Large North American meat plants stop slaughter after JBS cyberattack
RE
05/31CRAWFORD MPANY  : Adjuster spotlight - Jeannette Reed
PU
More news
Financials (USD)
Sales 2021 1 034 M - -
Net income 2021 31,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 15,4x
Yield 2021 2,60%
Capitalization 499 M 499 M -
Capi. / Sales 2021 0,48x
Capi. / Sales 2022 0,47x
Nbr of Employees 7 947
Free-Float 49,6%
Chart CRAWFORD & COMPANY
Duration : Period :
Crawford & Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRAWFORD & COMPANY
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 12,00 $
Last Close Price 9,22 $
Spread / Highest target 30,2%
Spread / Average Target 30,2%
Spread / Lowest Target 30,2%
EPS Revisions
Managers and Directors
NameTitle
Rohit Verma Chief Executive Officer & Director
Joseph Odilo Blanco President & Director
William Bruce Swain Chief Financial Officer & Executive Vice President
Michelle E. Jarrard Non-Executive Chairman
Andrew Bart President-Global Technical Services
Sector and Competitors
1st jan.Capitalization (M$)
CRAWFORD & COMPANY27.64%501
ALLIANZ SE7.95%108 245
CHUBB LIMITED9.21%74 855
MARSH & MCLENNAN COMPANIES, INC.20.20%71 006
ZURICH INSURANCE GROUP LTD-0.54%61 357
BAJAJ FINSERV LIMITED33.91%25 935